News
Academy
Publications
All Publications
eBooks
Media
Editorial Podcasts
Editorial Videos
Peer Exchange
Practice Academy
Shorts
Sponsored Podcasts
Sponsored Videos
More
Conferences
Conference Coverage
Conference Listing
Columns
All Columns
A Closing Thought
Clinical Trial Insights
View from Brussels
View from Washington
Resources
Advertise
Blogs
Events
Front & Center
Partner Perspectives
White Papers
Events
Webcasts
Event Calendar
Subscribe
My Account
News
Academy
Publications
Media
Conferences
Columns
Resources
Events
Subscribe
Event Calendar
Clinical Operations & Strategy
Decentralized Clinical Trials
Trial Design
Investigative Sites
CRO/Sponsor
Risk-Based Monitoring
Protocol Design
Clinical Trial Supply Chain
Study Start-Up
Early Phase Development
DEI
Industry Initiatives
Diversity Action Plans
Recruitment
Data Management
Analytics
Electronic Data Capture
Real World Evidence
Metrics & Benchmarks
Patient Participation
Integrated Research
CRAACO
Enrollment
Regulatory
Institutional Review Board & Ethics Committee
FDA
EMA
Technology
Artificial Intelligence/Machine Learning
eClinical
mHealth
Choose Specialty
Spotlight -
Conference Coverage
|
Peer Exchange
|
DE&I
|
Editorial Videos
|
Clinical Operations & Strategy
|
Patient Participation
Advertisement
Pablo Fernandez
Advertisement
Articles by Pablo Fernandez
The Increasing Role of Biosimilars
By
Pablo Fernandez
May 4th 2012
Applied Clinical Trials
Advertisement
Latest Updated Articles
The Increasing Role of Biosimilars
May 4th 2012
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Moving Beyond Disappointing Pilots: Scaling Adoption of AI-Enablement in Drug Development
2
ACT Brief: Patient-Site Trust Barriers, Rare Disease Evidence Without Registry, and RWD Enrollment Accuracy
3
How AI Is Changing Endpoint Selection Before a Trial Even Starts
4
When There’s No Registry: Building Rare Disease Evidence That Supports Regulatory Scrutiny
5
Sponsor Oversight in an Outsourced Trial: What Good Looks Like and How to Evidence It